🇺🇸 FDA
Patent

US 9567643

Compositions and methods for treating cancers

granted A61KA61K31/4745A61K31/706

Quick answer

US patent 9567643 (Compositions and methods for treating cancers) held by APTOSE BIOSCIENCES INC. expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
APTOSE BIOSCIENCES INC.
Grant date
Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4745, A61K31/706, A61K45/06, A61K49/0004